NMPA Approval

Levocetirizine Dihydrochloride Oral Solution

Approval Number

国药准字H20234579

Company福安药业集团湖北人民制药有限公司

Registration Date

December 5, 2023

Drug Information

Generic Name

盐酸左西替利嗪口服溶液

Dosage Form

口服溶液剂

Strength

0.05%（75ml:37.5mg）

Drug Type

化学药品

Registration Date

December 5, 2023

Company Information

Applicant Company

Company Name福安药业集团湖北人民制药有限公司

Company Address

湖北省武汉市东西湖区柏泉祁家山特1号

Manufacturing Company

Company Name福安药业集团湖北人民制药有限公司

Company Address

湖北省武汉市东西湖区柏泉祁家山特1号

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Product

Company

Legal

© 2025 MedPath, Inc. All rights reserved.

盐酸左西替利嗪口服溶液 - NMPA 批准文号 | MedPath